Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Summit Therapeutics Inc. (SMMT) News - StockMarketCap

Stocks›Summit Therapeutics Inc.☆

● At closeAs of Jul 2, 2026

Summit Therapeutics Inc.

SMMT✓

HealthcareBiotechnologyNASDAQ

$15.42+7.23%

$11.97BMarket cap

-10.40xP/E ratio

7.08MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$15.42

$1.04 (+7.23%) · 24h

Key metrics

Market cap$11.97B-7.26%

Enterprise value$11.24B

Volume (24h)7.08M

P/E ratio (TTM)-10.40x

P/S ratio (TTM)0.00x

Dividend yield0.00%

Shares outstanding776.16M

Trading range

Previous close$14.38

Day range$14.55 - $15.69

52-week range$12.55 - $30.98

Summit Therapeutics Inc. (SMMT) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news